Embrace Test- D&m

25 Questions

Settings
Please wait...
Embrace Test- D&m

.


Questions and Answers
  • 1. 
    Hyperglycemia in diabetes can be due to _________________.
    • A. 

      Insulin Resistance.

    • B. 

      Beta Cell Dysfunction

    • C. 

      Both Insulin resistance & Beta cell dysfunction at the same time.

    • D. 

      All of the Options.

  • 2. 
    Beta cells of pancreas produce a hormone __________.
    • A. 

      GLP-1

    • B. 

      GIP

    • C. 

      Insulin

    • D. 

      All the Options

  • 3. 
    The phenomena of much greater increase in insulin levels followed by oral glucose compared to same amount of glucose given intravenously is called as _________.
    • A. 

      Secretagogue effect

    • B. 

      Insulin effect

    • C. 

      Sensitizer effect

    • D. 

      Incretin effect

  • 4. 
    Xilia has a primary site of action on _______.
    • A. 

      Liver

    • B. 

      Pancreas

    • C. 

      GI-Track

    • D. 

      Adipose Tissues

  • 5. 
    Vysov belongs to _______ class of anti-diabetic drug. 
    • A. 

      Sulfonylureas

    • B. 

      Insulin’s

    • C. 

      DPP-4 Inhibitors

    • D. 

      All of the Options

  • 6. 
    Diabetic Peripheral Neuropathy is a micro vascular complication of diabetes in which patients can experience symptoms like _________
    • A. 

      Burning in feet

    • B. 

      Pain

    • C. 

      Pins & needles

    • D. 

      All the Options

  • 7. 
    Punch line of Vysov is "Expedite Control and Extend Protection"
    • A. 

      True

    • B. 

      False

  • 8. 
    Punch Line of Xilia-M is "Add Sweetness to Life".
    • A. 

      True

    • B. 

      False

  • 9. 
    Vysov-M is Indicated in T2DM Patients uncontrolled on mono therapy of metformin.
    • A. 

      True

    • B. 

      False

  • 10. 
    Xilia MP is Indicated in T2DM patients uncontrolled on dual therapy
    • A. 

      True

    • B. 

      False

  • 11. 
    What is the Punchline of Xilia MP
    • A. 

      Add Sweetness to Life

    • B. 

      Expedite Control and Extend Protection

    • C. 

      Control Assured and Safety Insured

    • D. 

      All the Options

  • 12. 
    Xilia Trio is a composition of _____________
    • A. 

      Glimepiride + Metformin

    • B. 

      Glimepiride + Metformin + Pioglitazone

    • C. 

      Glimepiride + Metformin + Voglibose

    • D. 

      None of the Options

  • 13. 
    ____________ is the Indication of Xilia Trio for T2DM Patients
    • A. 

      Newly Diabetes Detected Patients

    • B. 

      Patients Uncontrolled on Monotherapy

    • C. 

      Patients Uncontrolled on Dual Therapy

    • D. 

      None of the Options

  • 14. 
    Hosit Plus is Indicated in ____________
    • A. 

      Severe Diabetic Neuropathy

    • B. 

      Mild to Moderate Diabetic Neuropathy

    • C. 

      Neuropathic Pain

    • D. 

      None of the Options

  • 15. 
    GABA Hosit is Indicated in Patients with Painful Diabetic Neuropathy
    • A. 

      True

    • B. 

      False

  • 16. 
    GLP-1 Stands for ____________________ .
    • A. 

      Glucagon like Pesticide-1

    • B. 

      Glucagon like Poly Peptide-1

    • C. 

      Glucagon Like Peptide-1

    • D. 

      None of the Options

  • 17. 
    GIP Stands for ___________
    • A. 

      Glucose dependent Poly peptide

    • B. 

      Glucose dependent Insulinotropic Polypeptide

    • C. 

      Glucose Insulin Peptide

    • D. 

      None of the Options

  • 18. 
    DPN Stands for __________________
    • A. 

      Diabetic Peripheral Neuropathy

    • B. 

      Dual Peripheral Neuron

    • C. 

      Diabetic Painful Neuropathy

    • D. 

      None of the Options

  • 19. 
    DPP-4 Stands for ____________
    • A. 

      Dual Peptide Peptase-4

    • B. 

      Di Peptide Protease-4

    • C. 

      Dipeptidyl peptidase-4

    • D. 

      All the Options

  • 20. 
    Januvia is the competitor of Vysov from Novartis
    • A. 

      True

    • B. 

      False

  • 21. 
    Galvus-Met is the Brand of Linagliptin from Novartis
    • A. 

      True

    • B. 

      False

  • 22. 
    Amaryl is a competitor of Xilia from Sanofi
    • A. 

      True

    • B. 

      False

  • 23. 
    Glycomet-GP is competitor of Xilia M from Intas Pharma
    • A. 

      True

    • B. 

      False

  • 24. 
    Neurokind Plus is a competitor of Hosit Plus from Mankind Pharma
    • A. 

      True

    • B. 

      False